<DOC>
	<DOCNO>NCT01586117</DOCNO>
	<brief_summary>The purpose study evaluate effect intrarectal Amifostine administration acute radiation-induced rectal toxicity pre-operative chemo-radiotherapy .</brief_summary>
	<brief_title>A Phase II Study Amifostine Prevention Acute Radiation-Induced Rectal Toxicity</brief_title>
	<detailed_description>To evaluate different use way intrarectal Amifostine administration acute radiation-induced rectal toxicity pre-operative chemo-radiotherapy .</detailed_description>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Amifostine</mesh_term>
	<criteria>pathologically confirm rectal cancer , preoperative stage II / III ( T34N0 T14N + M0 ) . tumor distance anus le 12 cm . KPS score less 70 tolerate chemotherapy radiotherapy . pelvic history radiation therapy . Nonallergic history fluorouracil platinumbased chemotherapy drug . blood pressure control drug normal range ( 90 ≤ systolic blood pressure ≤ 140,60 ≤ diastolic blood pressure ≤ 90 ) . full understanding study , ability complete treatment plan , follow condition sign inform consent . malignancy ( past time ) , include curable nonmelanoma skin cancer cervical carcinoma situ ; include resectable primary colon cancer ( synchronous metachronous ) . pregnant lactating patient . fertility use contraceptive measure . exist active infection . merge serious complication , tolerate treatment , 6 month myocardial infarction , mental illness , uncontrollable diabetes uncontrollable hypertension hypotension . concurrent treatment anticancer drug . complete treatment followup .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>rectal cancer</keyword>
	<keyword>amifostine</keyword>
	<keyword>pre-operative chemo-radiation</keyword>
</DOC>